Charles Schoch serves as Executive at Candel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Charles Schoch has executed 2 insider transactions totaling $117.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 17, 2024 involved selling 9,884 shares valued at $63.9K.
Charles Schoch currently holds 62,520 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Schoch has been a net seller of CADL stock. They have purchased $0 and sold $117.1K worth of shares.
Charles Schoch's most recent insider trade was on Jul 17, 2024, when they sold 9,884 shares at $6.47 per share.
Get notified when new Form 4 filings are submitted
| $5.97 |
| Discretionary |